Join the Engerix-B group to help and get support from people like you.
Engerix-B News
CureVac’s Coronavirus Vaccine at the Center of a Fight for Control
CureVac, a German biopharmaceutical company, has hit the headlines after US President Trump tried to secure exclusive rights to its developmental coronavirus vaccine. The vaccine is being developed...
Dynavax Announces FDA Approval of Heplisav-B for Prevention of Hepatitis B in Adults
BERKELEY, CA – (Marketwired) – November 9, 2017 – Dynavax Technologies Corporation (NASDAQ: DVAX) today announced that the U.S. Food and Drug Administration (FDA) has approved Heplisav-B...